Showing results (311-320 of 335) with videos related to
Sort By:
Pageof 34
Cancer Chemotherapy and Pharmacology|January 1, 1994
Outcomes of 116 patients with hepatocellular carcinomaH Onodera, K Ukai, N Nakano, et al.Protein Engineering, Design & Selection : PEDS|February 18, 2010
Reduced elimination of IgG antibodies by engineering the variable regionT Igawa, H Tsunoda, T Tachibana, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|July 1, 1996
Estimate criteria for efficacy of treatment in benign prostatic hyperplasiaY Homma, K Kawabe, T Tsukamoto, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|March 1, 1997
Preoperative endocrine therapy for clinical stage A2, B, and C prostate cancer: an interim report on short-term effects. Prostate Cancer Study GroupY Homma, H Akaza, K Okada, et al.Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 1, 1991
World Health Organization Consensus Committee recommendations concerning the diagnosis of BPHA T Cockett, Y Aso, L Denis, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|July 1, 1996
Estimate criteria for diagnosis and severity in benign prostatic hyperplasiaY Homma, K Kawabe, T Tsukamoto, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|June 22, 1999
Early results of radical prostatectomy and adjuvant endocrine therapy for prostate cancer with or without preoperative androgen deprivation. The Prostate Cancer Study GroupY Homma, H Akaza, K Okada, et al.Endocrine Regulations|May 12, 2015
Self-awareness of fast eating and its impact on diagnostic components of metabolic syndrome among middle-aged Japanese males and femalesA Nohara, Y Maejima, K Shimomura, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 8, 2000
[A late phase II study of raltitrexed (ZD 1694) in chemotherapy-naive patients with advanced colorectal cancer]I Nishisho, N Kikkawa, T Ebata, et al.Urology|April 1, 1997
Assessment of hormone refractory prostate cancerD Newling, S D Fosså, L Andersson, et al.Pageof 34